hang on, being in phase 3 means the results were solid in previous phases, so dont give me rubbish like that
Ann: Noxopharm Set to Benefit From Novartis ASCO Data, page-5
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
-0.005(4.55%) |
Mkt cap ! $32.14M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 11.5¢ | 10.5¢ | $18.63K | 165.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 37127 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 105251 | 2 |
View Market Depth
| Last trade - 14.24pm 26/08/2024 (20 minute delay) ? |
| NOX (ASX) Chart |